Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Recruiting now · Not applicable

Conditions studied: Blood And Marrow Transplantation

In brief

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Key facts

Study ID

NCT02438904

Run by

M.D. Anderson Cancer Center

People needed

200

Starts

2015-05-06

Expected to finish

2027-05-01

Last updated by the study team

2026-05-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have poor or no graft function post stem cell transplantation.

You may not qualify if…

• N/A

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.